The present invention relates to the use of systems involved in ROS generation (reactive oxygen species) to reduce resistance to chemotherapy and radiation therapy, reduce cancer stem cell formation and inhibit the metastatic phenotype; the subject matter of the invention further relates to inhibitors of ROS generation serving to reduce resistance to chemotherapy and radiation therapy and inhibit cancer stem cell formation and inhibit the metastatic phenotype.
Method for reducing the resistance to anticancer drugs, radioresistance and cancer stem cells formation and metastatic phenotype
mancini a
2016
Abstract
The present invention relates to the use of systems involved in ROS generation (reactive oxygen species) to reduce resistance to chemotherapy and radiation therapy, reduce cancer stem cell formation and inhibit the metastatic phenotype; the subject matter of the invention further relates to inhibitors of ROS generation serving to reduce resistance to chemotherapy and radiation therapy and inhibit cancer stem cell formation and inhibit the metastatic phenotype.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
